During the past decade, Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator, "Hemophilia of Georgia, Inc." with 1 trials as a collaborator, "Octapharma" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital" are "Haemophilia A Without Inhibitor" (2 trials), "Haemophilia B Without Inhibitor" (2 trials), "Hemophilia" (2 trials), "Hemophilia A With Inhibitor" (2 trials) and "Hemophilia B With Inhibitor" (2 trials). Many other conditions were trialed in "Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital" in a lesser frequency.

The vast majority of trials in "Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".